Converging neurotrophic-immune signaling in autism spectrum disorder
Comments Off on Converging neurotrophic-immune signaling in autism spectrum disorder
June 3, 2026
This review examines the role of four interconnected signaling pathways in autism spectrum disorder. Among them, IGF-1 shows clinical trial support, while others remain preclinical or mechanistic.
Endocannabinoid System: Cannabis Clinical Research for ASD
Comments Off on Endocannabinoid System: Cannabis Clinical Research for ASD
April 26, 2026
Cannabis clinical research for autism spectrum disorder shows preliminary evidence for reducing irritability and behavioral symptoms. Clinical trial data remains limited and heterogeneous. Safety profiles in pediatric populations require further…
Endocannabinoid Research: Cannabis Use in Pregnancy & ASD
Comments Off on Endocannabinoid Research: Cannabis Use in Pregnancy & ASD
April 14, 2026
Maternal cannabis use pregnancy risks include a small but measurable increase in autism spectrum disorder and ADHD in offspring. Cannabis compounds cross the placenta and may affect fetal brain development. Current evidence advises avoiding cannabis use…